Nature Reviews: Drug Discovery 2008-12-01

End of the line for cannabinoid receptor 1 as an anti-obesity target?

Dan Jones

Index: Nat. Rev. Drug Discov. 7(12) , 961-2, (2008)

Full Text: HTML

Abstract

A wave of terminations of development programmes for cannabinoid receptor 1 blockers for obesity indicates the demise of a drug class that was once anticipated to yield blockbusters. Nevertheless, lessons learned might help salvage something for future such approaches.